The global transfection technologies market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for gene therapy and rising number of research centers and academic/government institutes. The lipofection segment accounted for the largest share in the global transfection technologies market in 2018, followed by electroporation and nucleofection segments. The research centers & academic/government institutes segment accounted for the largest share in the global transfection technologies market in 2018, followed by hospitals & clinics and pharmaceutical & biotechnology companies segments respectively. North America was estimated to account for the largest share of this market in 2018, followed by Europe and Asia Pacific respectively.
Global Transfection Technologies Market By Type (Lipofection, Electroporation, Nucleofection), By Application (Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies) And By Region (North America, Latin America, Europe, Asia Pacific And Middle East And Africa), Forecast From 2021 To 2030.
Some Of The Growth Factors Of This Market:
- The market for transfection technologies is expected to reach $3,890 million by 2022.
- Transfection technologies are used in the field of biotechnology and molecular biology to introduce DNA into cells or other living organisms.
- Transfection technology can be used in gene therapy.
Industry Growth Insights published a new data on “Transfection Technologies Market”. The research report is titled “Transfection Technologies Market research by Types (Lipofection, Electroporation, Nucleofection, Others), By Applications (Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), By Players/Companies Bio-Rad, Polyplus Transfection, MaxCyte, Promega Corporation, Thermo Fisher Scientific, Affymetrix, Agilent Technologies, Altogen Biosystems, Boca Scientific, Chemicell, CytoPulse, Clontech, Deliverics, GE Healthcare Life Sciences, IBA GmbH, Lonza, Inovio Pharmaceuticals, Merck KGaA, Miltenyi Biotec, Oz Biosciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transfection Technologies Market Research Report
By Type
Lipofection, Electroporation, Nucleofection, Others
By Application
Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others
By Companies
Bio-Rad, Polyplus Transfection, MaxCyte, Promega Corporation, Thermo Fisher Scientific, Affymetrix, Agilent Technologies, Altogen Biosystems, Boca Scientific, Chemicell, CytoPulse, Clontech, Deliverics, GE Healthcare Life Sciences, IBA GmbH, Lonza, Inovio Pharmaceuticals, Merck KGaA, Miltenyi Biotec, Oz Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Transfection Technologies Market Report Segments:
The global Transfection Technologies market is segmented on the basis of:
Types
Lipofection, Electroporation, Nucleofection, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad
- Polyplus Transfection
- MaxCyte
- Promega Corporation
- Thermo Fisher Scientific
- Affymetrix
- Agilent Technologies
- Altogen Biosystems
- Boca Scientific
- Chemicell
- CytoPulse
- Clontech
- Deliverics
- GE Healthcare Life Sciences
- IBA GmbH
- Lonza
- Inovio Pharmaceuticals
- Merck KGaA
- Miltenyi Biotec
- Oz Biosciences
Highlights of The Transfection Technologies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lipofection
- Electroporation
- Nucleofection
- Others
- By Application:
- Research Centers & Academic/Government Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transfection Technologies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transfection Technologies is a company that specializes in the delivery of genes and other genetic material into cells.
Some of the major players in the transfection technologies market are Bio-Rad, Polyplus Transfection, MaxCyte, Promega Corporation, Thermo Fisher Scientific, Affymetrix, Agilent Technologies, Altogen Biosystems, Boca Scientific, Chemicell, CytoPulse, Clontech, Deliverics, GE Healthcare Life Sciences, IBA GmbH, Lonza, Inovio Pharmaceuticals, Merck KGaA, Miltenyi Biotec, Oz Biosciences.
The transfection technologies market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transfection Technologies Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transfection Technologies Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transfection Technologies Market - Supply Chain
4.5. Global Transfection Technologies Market Forecast
4.5.1. Transfection Technologies Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transfection Technologies Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transfection Technologies Market Absolute $ Opportunity
5. Global Transfection Technologies Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transfection Technologies Market Size and Volume Forecast by Type
5.3.1. Lipofection
5.3.2. Electroporation
5.3.3. Nucleofection
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transfection Technologies Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transfection Technologies Market Size and Volume Forecast by Application
6.3.1. Research Centers & Academic/Government Institutes
6.3.2. Hospitals & Clinics
6.3.3. Pharmaceutical & Biotechnology Companies
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transfection Technologies Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transfection Technologies Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transfection Technologies Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transfection Technologies Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transfection Technologies Demand Share Forecast, 2019-2026
9. North America Transfection Technologies Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transfection Technologies Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transfection Technologies Market Size and Volume Forecast by Application
9.4.1. Research Centers & Academic/Government Institutes
9.4.2. Hospitals & Clinics
9.4.3. Pharmaceutical & Biotechnology Companies
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transfection Technologies Market Size and Volume Forecast by Type
9.7.1. Lipofection
9.7.2. Electroporation
9.7.3. Nucleofection
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transfection Technologies Demand Share Forecast, 2019-2026
10. Latin America Transfection Technologies Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transfection Technologies Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transfection Technologies Market Size and Volume Forecast by Application
10.4.1. Research Centers & Academic/Government Institutes
10.4.2. Hospitals & Clinics
10.4.3. Pharmaceutical & Biotechnology Companies
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transfection Technologies Market Size and Volume Forecast by Type
10.7.1. Lipofection
10.7.2. Electroporation
10.7.3. Nucleofection
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transfection Technologies Demand Share Forecast, 2019-2026
11. Europe Transfection Technologies Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transfection Technologies Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transfection Technologies Market Size and Volume Forecast by Application
11.4.1. Research Centers & Academic/Government Institutes
11.4.2. Hospitals & Clinics
11.4.3. Pharmaceutical & Biotechnology Companies
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transfection Technologies Market Size and Volume Forecast by Type
11.7.1. Lipofection
11.7.2. Electroporation
11.7.3. Nucleofection
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transfection Technologies Demand Share, 2019-2026
12. Asia Pacific Transfection Technologies Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transfection Technologies Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transfection Technologies Market Size and Volume Forecast by Application
12.4.1. Research Centers & Academic/Government Institutes
12.4.2. Hospitals & Clinics
12.4.3. Pharmaceutical & Biotechnology Companies
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transfection Technologies Market Size and Volume Forecast by Type
12.7.1. Lipofection
12.7.2. Electroporation
12.7.3. Nucleofection
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transfection Technologies Demand Share, 2019-2026
13. Middle East & Africa Transfection Technologies Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transfection Technologies Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transfection Technologies Market Size and Volume Forecast by Application
13.4.1. Research Centers & Academic/Government Institutes
13.4.2. Hospitals & Clinics
13.4.3. Pharmaceutical & Biotechnology Companies
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transfection Technologies Market Size and Volume Forecast by Type
13.7.1. Lipofection
13.7.2. Electroporation
13.7.3. Nucleofection
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transfection Technologies Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transfection Technologies Market: Market Share Analysis
14.2. Transfection Technologies Distributors and Customers
14.3. Transfection Technologies Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bio-Rad
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Polyplus Transfection
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. MaxCyte
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Promega Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher Scientific
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Affymetrix
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Agilent Technologies
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Altogen Biosystems
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Boca Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chemicell
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. CytoPulse
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Clontech
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Deliverics
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. GE Healthcare Life Sciences
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. IBA GmbH
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Lonza
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Inovio Pharmaceuticals
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Merck KGaA
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Miltenyi Biotec
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Oz Biosciences
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
